ChemoCentryx's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the ChemoCentryx Fourth Quarter 2013 Financial Results Conference Call.
Thursday Mar 13
ChemoCentryx Announces Financial Results for the Quarter and Year Ended December 31, 2013
ChemoCentryx, Inc., , a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, announced today its financial results for the fourth quarter and year ended December 31, 2013.
ChemoCentryx, Inc. To Hold Fourth Quarter And Year-End 2013 Financial ...
ChemoCentryx, Inc. announced today that the Company's fourth quarter and year-end 2013 financial results will be released after market close on Thursday, March 13, 2014.
ChemoCentryx, Inc. To Present At The 34th Annual Health Care Conference
ChemoCentryx, Inc. , today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the Cowen and Company 34th Annual Health Care Conference on Tuesday, March 4, 2014, at 10:40 a.m. Eastern Time at The Boston Marriott Copley Place hotel in Boston, MA.
Partnership Could Mean High Alpha For ChemoCentryx
ChemoCentryx is a biopharmaceutical smallcap whose pipeline & process  are oriented on the development of chemokine pathway drugs .